In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BBI Diagnostics Group PLC

www.the-bbigroup.com

Latest From BBI Diagnostics Group PLC

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals

Medical Device Deals Update, August 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced June-July 2015.

Medical Device Deals

Deals Shaping The Medical Industry, July/August 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Urine-based Testing
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Research, Analytical Equipment & Supplies
  • Services
  • Therapeutic Areas
  • Cardiovascular
  • Gynecological, Urological
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • BBI Diagnostics Group PLC
  • Senior Management
  • Lyn Rees, CEO
    Anne Hyland, CFO
    Leigh Thomas, Chief Commercial Officer
  • Contact Info
  • BBI Diagnostics Group PLC
    Phone: (0) 2920 747 232
    The Courtyard
    73 Ty Glas Ave.
    Llanishen, Cardiff, CF14 5DX
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register